Swiss Re's latest sigma study projects slower global insurance premium growth and economic expansion due to increased US tariffs, with the US market most affected.

Tariffs on medical imports have led U.S. health plans to plan premium increases for 2025 due to rising drug and device costs, impacting payer pricing strategies and market outlooks.

Explore how Trump administration cuts to NIH funding, public health grants, and potential Medicaid changes disrupt U.S. health care research, public health efforts, and patient care access.

Policy unpredictability, rising insurance and tax costs, and trade tensions are slowing the U.S. housing market recovery in 2019, creating cautious consumer behavior and a weak summer buying season outlook.

Explore how Georgia's tort reform, manufacturing tariffs, automotive regulations, and AI advancements are shaping the U.S. insurance industry landscape in 2024.

U.S. property/casualty insurance posts strongest underwriting results since 2013 with improved combined ratios and premium growth; 2025 outlook tempered by wildfire losses and tariff impacts on costs.

U.S. inflation eases to a four-year low in April, reflecting early tariff impacts and varied sector price movements. Persistent inflation pressures and tariff-related costs influence economic and insurance market trends.

Tariffs on imported construction materials are projected to raise U.S. home insurance premiums by $106 on average in 2025, impacting rebuilding costs and coverage requirements nationwide.

Tariffs on imported construction materials could raise average U.S. home insurance premiums by $106 in 2025, driven by higher rebuilding costs and supply chain effects.

New 25% tariffs on imported auto parts will increase U.S. car repair expenses and insurance premiums, impacting both new and used vehicle markets, with significant effects on states like New York and Florida.